Health Catalyst
HCAT
126 hedge funds and large institutions have $104M invested in Health Catalyst in 2026 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 33 increasing their positions, 43 reducing their positions, and 34 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
88% more call options, than puts
Call options by funds: $5.98M | Put options by funds: $3.19M
47% more capital invested
Capital invested by funds: $70.9M → $104M (+$33.1M)
3% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 34
4% less funds holding
Funds holding: 131 → 126 (-5)
5.17% less ownership
Funds ownership: 75.87% → 70.7% (-5.2%)
23% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVM
Palogic Value Management
Dallas,
Texas
|
+$2.92M |
| 2 |
Impax Asset Management Group
London,
United Kingdom
|
+$1.8M |
| 3 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
+$1.59M |
| 4 |
Jane Street
New York
|
+$1.46M |
| 5 |
CF
CDC Financial
Chicago,
Illinois
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
|
-$5.92M |
| 2 |
BlackRock
New York
|
-$4.77M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.39M |
| 4 |
JP Morgan Chase
New York
|
-$976K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$881K |
HCAT Hedge Fund Activity: Q2 2026 in Review
126 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2026, worth a combined $104M — up 47% from $70.9M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of HCAT and 33 opened new positions — a net loss of 1 holder — while 43 trimmed existing stakes and 33 added.
The largest buyer was Palogic Value Management, adding an estimated $2.92M. The largest seller was Whetstone Capital Advisors, cutting an estimated $5.92M.
- 126 institutional investors held Health Catalyst (HCAT) as of Q2 2026, down from 131 in Q1 2026.
- Funds reported $104M of Health Catalyst stock for Q2 2026, up 47% quarter-over-quarter.
- 33 funds opened new Health Catalyst positions in Q2 2026 and 34 closed out, a net change of -1 holder.
- The largest Health Catalyst buyer in Q2 2026 was Palogic Value Management, an estimated $2.92M added.
- The largest Health Catalyst seller in Q2 2026 was Whetstone Capital Advisors, an estimated $5.92M sold.
Based on aggregated 13F filings for Q2 2026.